ClinicalTrials.gg
CompletedNCT07278180Updated Dec 18, 2025

Effects of Platelet and Leukocyte-rich Fibrin on Alveolar Ridge Maintenance Through Three-dimensional Analysis

An observational study in Caries Active, Tooth Decay and Tooth Loss / Rehabilitation, sponsored by University of Guarulhos. Completed. Open to participants aged 21 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-18.

Sponsored by University of Guarulhos · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
40
Ages
21 Years to 70 Years
Sex
All
01

Study summary

Understanding, through accurate and reliable volumetric analysis, how the biomaterial (LPRF) and the thickness of the vestibular bone plate influence changes in bone volume after extraction, is essential for making clinical decisions that impact implant-supported rehabilitation.

02

Conditions studied

  • Caries Active
  • Tooth Decay
  • Tooth Loss / Rehabilitation

Keywords

  • tooth loss
  • decay
  • caries
  • biomaterials
03

In context

Dental Caries

1,176 studies on the registry are indexed under Dental Caries; 209 are open to participants now.

This study's enrollment of 40 is below the median of 172 across 192 observational studies indexed under Dental Caries.

Browse Dental Caries studies →

Lead sponsor

University of Guarulhos is the lead sponsor of 17 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Subjects with indication of tooth extraction

Eligibility criteria

This prospective clinical study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and received approval from the Research Ethics Committee of Guarulhos University, São Paulo, Brazil (CEP-UnG #. 515.153). Thirty-nine patients (24 women and 15 men), aged between 22 and 80 years, who were in overall good health, non-diabetic, periodontally healthy, non-smokers, free of blood dyscrasias, not pregnant or lactating, and requiring extraction of non-contiguous, compromised teeth due to root fractures, caries, unsuccessful endodontic treatment, root resorption, or orthodontic reasons, were enrolled.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
40 participants (actual)
Patient registry
No

Groups and cohorts

  • platelet rich firbrin

    Procedure: Alveolar socket preservation with graft and flap surgery

Interventions

  • ProcedureAlveolar socket preservation with graft and flap surgery

    teeth to either the control group (coagulant-filled alveoli) or the test group (alveoli filled with platelet-rich fibrin and LPRF leukocytes)

06

What researchers measure

Primary outcomes

  1. bone volume after 16 weeks

    Time frame: 16 weeks

  2. aveolar bone contraction

    Time frame: 4 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2016 to primary completion in Feb 2018, 25 months.

Of 48 non-industry observational studies under Dental Caries, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 32. This study's 25 months is above that.

Counting every sponsor, half of 49 studies reached it within 12 months; a quarter within 7 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 29, 2025
First posted
Dec 11, 2025
StartActual
Jan 20, 2016
Primary completionActual
Feb 20, 2018
CompletionActual
Jan 20, 2022
Last update
Dec 18, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07278180
Lead sponsor
University of Guarulhos
Responsible party
Jamil awad shibli (Investigator, University of Guarulhos) — Principal investigator
First posted
Dec 11, 2025
Start date
Jan 20, 2016
Primary completion
Feb 20, 2018
Completion
Jan 20, 2022
Last update
Dec 18, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion